Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
Shaheer Ahmad, Debapriya Bhattacharya, Santosh K. Kar, Anand Ranganathan, Luc Van Kaer, Gobardhan Das
Infection and Immunity · 2019-08
Abstract
Tuberculosis (TB) is one of the deadliest diseases, causing ∼2 million deaths annually worldwide. Mycobacterium bovis bacillus Calmette-Guérin (BCG), the only TB vaccine in common use, is effective against disseminated and meningeal TB in young children but is not effective against adult pulmonary TB.
MeSH terms
- Mycobacterium bovis
- Mycobacterium tuberculosis
- Immune system
- Immunology
- Biology
- Tuberculosis
- Vaccine efficacy
- Curcumin
- BCG vaccine
- Interferon gamma
- Immunity
- Tuberculosis vaccines
- Antigen
- Virology